Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | BLUE |
---|---|---|
09:32 ET | 122704 | 3.82 |
09:33 ET | 33715 | 3.8 |
09:35 ET | 36991 | 3.78 |
09:37 ET | 36203 | 3.82 |
09:39 ET | 21035 | 3.815 |
09:42 ET | 10710 | 3.81 |
09:44 ET | 33330 | 3.805 |
09:46 ET | 35042 | 3.815 |
09:48 ET | 61895 | 3.815 |
09:50 ET | 10760 | 3.8294 |
09:51 ET | 19901 | 3.84 |
09:53 ET | 13200 | 3.8413 |
09:55 ET | 26764 | 3.84 |
09:57 ET | 8296 | 3.84 |
10:00 ET | 5344 | 3.83 |
10:02 ET | 47723 | 3.88 |
10:04 ET | 36509 | 3.885 |
10:06 ET | 14304 | 3.89 |
10:08 ET | 43189 | 3.865 |
10:09 ET | 8356 | 3.86 |
10:11 ET | 68395 | 3.87 |
10:13 ET | 24858 | 3.875 |
10:15 ET | 27775 | 3.87 |
10:18 ET | 18661 | 3.87 |
10:20 ET | 4178 | 3.875 |
10:22 ET | 10102 | 3.87 |
10:24 ET | 60991 | 3.905 |
10:26 ET | 9936 | 3.905 |
10:27 ET | 22711 | 3.8999 |
10:29 ET | 4979 | 3.88 |
10:31 ET | 14256 | 3.905 |
10:33 ET | 2376 | 3.9 |
10:36 ET | 11715 | 3.9 |
10:38 ET | 13273 | 3.905 |
10:40 ET | 4943 | 3.895 |
10:42 ET | 7487 | 3.9 |
10:44 ET | 6652 | 3.895 |
10:45 ET | 7197 | 3.91 |
10:47 ET | 2700 | 3.9 |
10:49 ET | 7779 | 3.89 |
10:51 ET | 5487 | 3.905 |
10:54 ET | 12180 | 3.895 |
10:56 ET | 10198 | 3.89 |
10:58 ET | 24136 | 3.91 |
11:00 ET | 5184 | 3.915 |
11:02 ET | 13195 | 3.9 |
11:03 ET | 13599 | 3.93 |
11:05 ET | 13070 | 3.9207 |
11:07 ET | 11139 | 3.96 |
11:09 ET | 8257 | 3.96 |
11:12 ET | 13253 | 3.9801 |
11:14 ET | 14215 | 3.99 |
11:16 ET | 26536 | 4 |
11:18 ET | 19417 | 4.025 |
11:20 ET | 91338 | 4.025 |
11:21 ET | 11241 | 4.025 |
11:23 ET | 10936 | 4.04 |
11:25 ET | 49075 | 4.0793 |
11:27 ET | 17559 | 4.08 |
11:30 ET | 49274 | 4.115 |
11:32 ET | 46815 | 4.105 |
11:34 ET | 30544 | 4.09 |
11:36 ET | 29077 | 4.1 |
11:38 ET | 18873 | 4.1052 |
11:39 ET | 37009 | 4.0993 |
11:41 ET | 24849 | 4.12 |
11:43 ET | 13519 | 4.11 |
11:45 ET | 15610 | 4.125 |
11:48 ET | 36513 | 4.13 |
11:50 ET | 23144 | 4.12 |
11:52 ET | 19395 | 4.1298 |
11:54 ET | 43446 | 4.14 |
11:56 ET | 8822 | 4.1299 |
11:57 ET | 17405 | 4.125 |
11:59 ET | 13091 | 4.115 |
12:01 ET | 27322 | 4.14 |
12:03 ET | 35558 | 4.13 |
12:06 ET | 13126 | 4.13 |
12:08 ET | 71454 | 4.165 |
12:10 ET | 9179 | 4.1686 |
12:12 ET | 33583 | 4.17 |
12:14 ET | 13159 | 4.18 |
12:15 ET | 18079 | 4.145 |
12:17 ET | 13653 | 4.115 |
12:19 ET | 8805 | 4.105 |
12:21 ET | 13316 | 4.11 |
12:24 ET | 15830 | 4.1185 |
12:26 ET | 9969 | 4.1167 |
12:28 ET | 1328 | 4.115 |
12:30 ET | 11835 | 4.105 |
12:32 ET | 21817 | 4.125 |
12:33 ET | 8361 | 4.125 |
12:35 ET | 13711 | 4.101 |
12:37 ET | 9661 | 4.11 |
12:39 ET | 1963 | 4.1197 |
12:42 ET | 3527 | 4.125 |
12:44 ET | 2499 | 4.1223 |
12:46 ET | 3318 | 4.1225 |
12:48 ET | 6356 | 4.13 |
12:50 ET | 9740 | 4.1125 |
12:51 ET | 12579 | 4.1 |
12:53 ET | 27482 | 4.09 |
12:55 ET | 35249 | 4.11 |
12:57 ET | 13724 | 4.115 |
01:00 ET | 25848 | 4.115 |
01:02 ET | 35688 | 4.07 |
01:04 ET | 23819 | 4.075 |
01:06 ET | 4997 | 4.0721 |
01:08 ET | 15377 | 4.0701 |
01:09 ET | 65302 | 4.045 |
01:11 ET | 10172 | 4.04 |
01:13 ET | 5935 | 4.04 |
01:15 ET | 5300 | 4.05 |
01:18 ET | 13398 | 4.06 |
01:20 ET | 16402 | 4.06 |
01:22 ET | 2695 | 4.06 |
01:24 ET | 8493 | 4.045 |
01:26 ET | 5170 | 4.035 |
01:27 ET | 8978 | 4.04 |
01:29 ET | 8999 | 4.03 |
01:31 ET | 11425 | 4.03 |
01:33 ET | 12315 | 4.03 |
01:36 ET | 16631 | 4.0525 |
01:38 ET | 2200 | 4.05 |
01:40 ET | 21674 | 4.0599 |
01:42 ET | 18668 | 4.055 |
01:44 ET | 20853 | 4.04 |
01:45 ET | 6171 | 4.04 |
01:47 ET | 13545 | 4.0599 |
01:49 ET | 31428 | 4.0788 |
01:51 ET | 32864 | 4.0809 |
01:54 ET | 1666 | 4.08 |
01:56 ET | 1400 | 4.08 |
01:58 ET | 4941 | 4.09 |
02:00 ET | 9373 | 4.1 |
02:02 ET | 22055 | 4.1192 |
02:03 ET | 55921 | 4.14 |
02:05 ET | 2050 | 4.135 |
02:07 ET | 10261 | 4.135 |
02:09 ET | 9403 | 4.13 |
02:12 ET | 1000 | 4.135 |
02:14 ET | 9824 | 4.125 |
02:16 ET | 47117 | 4.1391 |
02:18 ET | 25058 | 4.14 |
02:20 ET | 6725 | 4.134 |
02:21 ET | 6600 | 4.1213 |
02:23 ET | 9665 | 4.135 |
02:25 ET | 3121 | 4.125 |
02:27 ET | 27891 | 4.13 |
02:30 ET | 26213 | 4.1388 |
02:32 ET | 1194 | 4.1399 |
02:34 ET | 53153 | 4.165 |
02:36 ET | 29312 | 4.175 |
02:38 ET | 25676 | 4.16 |
02:39 ET | 39065 | 4.165 |
02:41 ET | 13414 | 4.16 |
02:43 ET | 26810 | 4.15 |
02:45 ET | 12604 | 4.145 |
02:48 ET | 17409 | 4.145 |
02:50 ET | 10718 | 4.15 |
02:52 ET | 7910 | 4.135 |
02:54 ET | 1200 | 4.13 |
02:56 ET | 12801 | 4.1422 |
02:57 ET | 14249 | 4.15 |
02:59 ET | 15500 | 4.1597 |
03:01 ET | 3622 | 4.155 |
03:03 ET | 29730 | 4.165 |
03:06 ET | 7029 | 4.165 |
03:08 ET | 39871 | 4.1601 |
03:10 ET | 1116 | 4.165 |
03:12 ET | 10891 | 4.18 |
03:14 ET | 40386 | 4.1799 |
03:15 ET | 12370 | 4.175 |
03:17 ET | 11696 | 4.165 |
03:19 ET | 12030 | 4.1725 |
03:21 ET | 62349 | 4.175 |
03:24 ET | 7691 | 4.176 |
03:26 ET | 48498 | 4.1852 |
03:28 ET | 46090 | 4.215 |
03:30 ET | 19228 | 4.2283 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
bluebird bio Inc | 417.7M | -5.7x | --- |
Fusion Pharmaceuticals Inc | 401.1M | -3.3x | --- |
Adlai Nortye Ltd | 405.9M | -6.3x | --- |
Oculis Holding AG | 357.5M | 0.0x | --- |
Oric Pharmaceuticals Inc | 431.0M | -4.1x | --- |
Entrada Therapeutics Inc | 432.8M | -17.3x | --- |
bluebird bio, Inc. is a biotechnology company. The Company is focused on researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its lentiviral vector (LVV) gene addition platform. Its lead gene therapy programs for sickle cell disease, B-thalassemia, and cerebral adrenoleukodystrophy and is advancing research to apply new technologies to these and other diseases. It has two gene therapies: ZYNTEGLO (betibeglogene autotemcel) and SKYSONA (elivaldogene autotemcel). ZYNTEGLO is the first gene therapy for people with B-thalassemia who require regular red blood cell transfusions. SKYSONA (elivaldogene autotemcel), also known as eli-cel, is used to slow the progression of eurologic dysfunction in boys 4-17 years of age with early, active cerebral adrenoleukodystrophy (CALD). It is also developing (lovotibeglogene autotemcel), also known as lovo-cel, as a one-time treatment for patients with sickle cell disease (SCD).
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $417.7M |
---|---|
Revenue (TTM) | $21.7M |
Shares Outstanding | 109.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.00 |
EPS | $-0.74 |
Book Value | $2.37 |
P/E Ratio | -5.7x |
Price/Sales (TTM) | 19.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -626.69% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.